AAAAAA

   
Results: 1-19 |
Results: 19
INCREASED LEVELS OF THE SOLUBLE ADHESION MOLECULE E-SELECTIN IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISORDERS AND THROMBOEMBOLIC COMPLICATIONS
Authors: MUSOLINO C ALONCI A ALLEGRA A SPATARI G BELLOMO G TRINGALI O QUARTARONE C SQUADRITO G QUARTARONE N
Citation: C. Musolino et al., INCREASED LEVELS OF THE SOLUBLE ADHESION MOLECULE E-SELECTIN IN PATIENTS WITH CHRONIC MYELOPROLIFERATIVE DISORDERS AND THROMBOEMBOLIC COMPLICATIONS, American journal of hematology, 57(2), 1998, pp. 109-112
TRANSLOCATION (5-10)(Q13-Q26) IN ACUTE MONOBLASTIC LEUKEMIA
Authors: PERNICE F MUSOLINO C MAZZA G PUGLISI D SQUADRITO G FRISINA N SQUADRITO G
Citation: F. Pernice et al., TRANSLOCATION (5-10)(Q13-Q26) IN ACUTE MONOBLASTIC LEUKEMIA, Cancer genetics and cytogenetics, 101(2), 1998, pp. 152-155
INCREASED CONCENTRATION OF CIRCULATING ACID GLYCOSAMINOGLYCANS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND ESSENTIAL THROMBOCYTHEMIA
Authors: CALABRO L MUSOLINO C SPATARI G VINCI R CALATRONI A
Citation: L. Calabro et al., INCREASED CONCENTRATION OF CIRCULATING ACID GLYCOSAMINOGLYCANS IN CHRONIC LYMPHOCYTIC-LEUKEMIA AND ESSENTIAL THROMBOCYTHEMIA, Clinica chimica acta, 269(2), 1998, pp. 185-199
THE IN-VITRO CYTOTOXIC EFFECT OF MITOXANTRONE IN COMBINATION WITH FLUDARABINE OR PENTOSTATIN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MORABITO F CALLEA I CONSOLE G STELITANO C SCULLI G FILANGERI M OLIVA B MUSOLINO C IACOPINO P BRUGIATELLI M
Citation: F. Morabito et al., THE IN-VITRO CYTOTOXIC EFFECT OF MITOXANTRONE IN COMBINATION WITH FLUDARABINE OR PENTOSTATIN IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, Haematologica, 82(5), 1997, pp. 560-565
CD34- PRELIMINARY-RESULTS OF A MULTICENTER STUDY( SELECTED PBSC AUTOGRAFT IN CLL )
Authors: SCIME R SANTORO A MUSSO M OLIVIERI A MOLICA S IACOPINO P MILONE G MUSOLINO C CAPALBO S MARIANI G LEONI P GIUSTOLISI R LISO V NARNI F DONELLI A MAJOLINO I
Citation: R. Scime et al., CD34- PRELIMINARY-RESULTS OF A MULTICENTER STUDY( SELECTED PBSC AUTOGRAFT IN CLL ), Experimental hematology, 25(8), 1997, pp. 319-319
RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR REVERTS VASCULAR DYSFUNCTION
Authors: SQUADRITO F ALTAVILLA D SQUADRITO G CAMPO GM IOCULANO M SERRANO M MINUTOLI L ARLOTTA M MUSOLINO C SAITTA A CAPUTI AP
Citation: F. Squadrito et al., RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR REVERTS VASCULAR DYSFUNCTION, International journal of microcirculation, clinical and experimental, 17(1), 1997, pp. 10-14
MONOCYTES AND LYMPHOCYTES AS ACTIVE PARTICIPANTS IN THE PATHOGENESIS OF EXPERIMENTAL SHOCK
Authors: ALTAVILLA D SQUADRITO F AMMENDOLIA L SQUADRITO G CAMPO GM CANALE P IOCULANO M MUSOLINO C ALONCI A SARDELLA A URNA G SAITTA A CAPUTI AP
Citation: D. Altavilla et al., MONOCYTES AND LYMPHOCYTES AS ACTIVE PARTICIPANTS IN THE PATHOGENESIS OF EXPERIMENTAL SHOCK, Inflammation research, 45(8), 1996, pp. 398-404
EVALUATION OF HEPATITIS-B AND HEPATITIS-C VIRUS-INFECTIONS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA AND WITHOUT LIVER-DISEASE
Authors: MUSOLINO C CAMPO S POLLICINO T SQUADRITO G SPATARI G RAIMONDO G
Citation: C. Musolino et al., EVALUATION OF HEPATITIS-B AND HEPATITIS-C VIRUS-INFECTIONS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA AND WITHOUT LIVER-DISEASE, Haematologica, 81(2), 1996, pp. 162-164
LEUKOCYTE INTEGRIN VERY LATE ANTIGEN-4 VASCULAR CELL-ADHESION MOLECULE-1 ADHESION PATHWAY IN SPLANCHNIC ARTERY-OCCLUSION SHOCK/
Authors: SQUADRITO F ALTAVILLA D AMMENDOLIA L SQUADRITO G CAMPO GM CANALE P IOCULANO M MUSOLINO C ALONCI A SAITTA A ROSSI F CAPUTI AP
Citation: F. Squadrito et al., LEUKOCYTE INTEGRIN VERY LATE ANTIGEN-4 VASCULAR CELL-ADHESION MOLECULE-1 ADHESION PATHWAY IN SPLANCHNIC ARTERY-OCCLUSION SHOCK/, European journal of pharmacology, 318(1), 1996, pp. 153-160
SERUM LEVELS OF SOLUBLE ICAM-1 IN PATIENTS WITH MALIGNANT-LYMPHOMA INASSOCIATION WITH TREATMENT RESPONSE
Authors: MUSOLINO C ALONCI A ALLEGRA A SPATARI G BELLOMO G QUARTARONE M
Citation: C. Musolino et al., SERUM LEVELS OF SOLUBLE ICAM-1 IN PATIENTS WITH MALIGNANT-LYMPHOMA INASSOCIATION WITH TREATMENT RESPONSE, British Journal of Haematology, 94(3), 1996, pp. 580-581
A PHASE-II TRIAL ON ALPHA-INTERFERON (ALPHA-IFN) EFFECT IN PATIENTS WITH MONOCLONAL IGM GAMMOPATHY
Authors: ROTOLI B DERENZO A FRIGERI F BUFFARDI S MARCENO R CAVALLARO AM RUGGERI P LISO V MUSTO P ANDRIANI A CALLEA V PIZZUTI M IANNITTO E CIMINO R MOLICA S CITARRELLA P MUSOLINO C GUARINO S LUCARELLI G ESPINOSA A DELVECCHIO L
Citation: B. Rotoli et al., A PHASE-II TRIAL ON ALPHA-INTERFERON (ALPHA-IFN) EFFECT IN PATIENTS WITH MONOCLONAL IGM GAMMOPATHY, Leukemia & lymphoma, 13(5-6), 1994, pp. 463-469
EFFECTIVE THERAPY OF APLASTIC-ANEMIA POSTHEPATITIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
Authors: MUSOLINO C ORLANDO A ALONCI A SANTORO MC BELLOMO G QUARTARONE M SQUADRITO G
Citation: C. Musolino et al., EFFECTIVE THERAPY OF APLASTIC-ANEMIA POSTHEPATITIS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN, American journal of hematology, 46(1), 1994, pp. 59-60
CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CD) VERSUS CD-PLUS-INTERFERON-ALPHA-2B (IFN-CD) FOR RESISTANT OR RELAPSED MULTIPLE-MYELOMA
Authors: MARCENO R BUSCEMI F FIANDACA T MOLICA S ALBERTI A RUGGERI P ARDIZZONE G DERENZO A ROTOLI B IANNITTO E ABBADESSA V MUSTO P CAROTENUTO M DERIU L CALLEA V ANDRIANI A MUSOLINO C PIZZUTI M RENNA S CARONIA F
Citation: R. Marceno et al., CYCLOPHOSPHAMIDE AND DEXAMETHASONE (CD) VERSUS CD-PLUS-INTERFERON-ALPHA-2B (IFN-CD) FOR RESISTANT OR RELAPSED MULTIPLE-MYELOMA, Experimental hematology, 22(8), 1994, pp. 734-734
INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA
Authors: TURA S BACCARANI M ZUFFA E RUSSO D ZACCARIA A FIACCHINI M TESTONI N ZAMAGNI MD MARTINELLI G DAMIANI D MICHIELI M FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C ALIMENA G MANDELLI F LEONI P DANIELI G NOSARI A DECATALDO F MAJOLINO I CARONIA F LIBERATI AM GRIGNANI F TABILIO A MARTELLI M PAOLINO F RESEGOTTI L DITUCCI A BROCCIA G LEONI F CIOLLI S LUCIANO L ROTOLI B PERRICONE R CAJOZZO A MONTUORO A DELAURENZI A VOLPE E DEMILIO A BATTISTA R CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL LOMBARDO M TORLONTANO G LANDOLFI R LEONE G DELFINI C SPARAVENTI G PAPINESCHI F SPREMOLLA G RISSO M MARMONT AM DINI D DIPRISCO U MANGONI L RIZZOLI V GIRINO M ASCARI E BODENIZZA CA CAROTENUTO M DIFRANCESCO A QUAGLINO D NARDELLI S CICCONE F MIRAGLIA E DEBIASE R GALLO E PILERI A RAMBALDI A BARBUI T MORANDI S BIANCHINI E DEROSA C CIMINO R RONCA F NOBILE F CANTONETTI M PAPA G GALLAMINI A BUFFA F MUSOLINO C SQUADRITO G CAPALDI A GIOVANNELLI E PINOTTI G VENCO A ZAGONEL V PINTO A GENTILINI I COSER P GUGLIELMO P CACCIOLA E PIZZUTI M RICCIUTI F FANIN R CRISCUOLO D MONTEFUSCO E
Citation: S. Tura et al., INTERFERON ALFA-2A AS COMPARED WITH CONVENTIONAL CHEMOTHERAPY FOR THETREATMENT OF CHRONIC MYELOID LEUKEMIA, The New England journal of medicine, 330(12), 1994, pp. 820-825
WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT
Authors: ZACCARIA A MARTINELLI G BUZZI M FARABEGOLI P SAGLIO G GUERRASIO A BERNABEI PA SANTINI V PELLICCI PG MENCARELLI A COCO FL DIVERIO D RAMBALDI A SANTORO A TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A MARTELLI M RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: A. Zaccaria et al., WILL MOLECULAR-BIOLOGY CONTRIBUTE TO REFINE PROGNOSIS AND TO SELECT TREATMENT, Leukemia & lymphoma, 11, 1993, pp. 81-89
TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE
Authors: TURA S RUSSO D ZUFFA E FANIN R PATRIARCA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI MD ZACCARIA A MONTEFUSCO E ALIMENA G MELONI G MANDELLI F DAMIANI D MICHIELI M CRISCUOLO D FOWST C HOLDENER EE SPECCHIA G LISO V MORRA E BERNASCONI C DEMILIO A BATTISTA R DITUCCI A BROCCIA G MAIOLINO I CARONIA F LUCIANO L ROTOLI B LEONI P DANIELI G BODENIZZA CA CAROTENUTO M ROTONDO SG NOSARI A DECATALDO F MONTUORO A DELAURENZI A CAMILLO S LIBERATI AM GRIGNANI F TABILIO A RAMBALDI A BARBUI T LEONI F CIOLLI S RONCA F NOBILE F PAOLINO F RESEGOTTI L PAPINESCHI F SPREMOLLA G LANDOLFI R LEONE G VOLPE E MANGONI L RIZZOLI V CAPUCCI A IZZI T SCAPOLI GL CASTOLDI GL GENTILINI I COSER P GALLO E PILERI A CANTONETTI M PAPA G DINI D DIPRISCO U MORANDI S BIANCHINI E PINOTTI G VENCO A ZAGONEL V PINTO A CAPALDI A GIOVANNELLI E PIZZUTI M RICCIUTI F AMBROSETTI A PERONA G PERRICONE R CAJOZZO A LOMBARDO M TORLONTANO G DELFINI C LUCARELLI G GIRINO M ASCARI E RISSO M DAMASIO E MARTINO S PARDINI S LONGINOTTI M MIRAGLIA E DEBIASE R NARDELLI S CICCONE F GALIENI P DISPENSA E ABBADESSA A BRUZZESE L PROSSOMARITI L CIMINO R DEROSA C GABBAS A FRANCESCO S GALLAMINI A DIFRANCESCO A QUAGLINO D MUSOLINO C SQUADRITO G AVANZINI P GOBBI F NUOVA ASM EMILIA R SAGLIO G AGLIETTA M CAMASCHELLA C MAZZA MU GUGLIELMO P CACCIOLA E MONACO M
Citation: S. Tura et al., TREATMENT OF PH-POSITIVE CHRONIC MYELOID-LEUKEMIA WITH ALPHA-INTERFERON (ROFERON-A) - THE ITALIAN COOPERATIVE STUDY-GROUP EXPERIENCE, Leukemia & lymphoma, 11, 1993, pp. 153-157
SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: MUSOLINO C GROSSO P ALONCI A ALLEGRA A ORLANDO A CINCOTTA M BUDA G SQUADRITO G
Citation: C. Musolino et al., SERUM LEVELS OF 2', 5 OLIGOADENYLATE SYNTHETASE DURING INTERFERON THERAPY IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA, American journal of hematology, 43(1), 1993, pp. 1-4
ISODICENTRIC PHILADELPHIA-CHROMOSOME IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA
Authors: PERNICE F SQUADRITO G SAITTA A MAZZA G MUSOLINO C
Citation: F. Pernice et al., ISODICENTRIC PHILADELPHIA-CHROMOSOME IN ACCELERATED PHASE OF CHRONIC MYELOID-LEUKEMIA, Cancer genetics and cytogenetics, 66(2), 1993, pp. 113-116
EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986
Authors: TURA S FANIN R RUSSO D ZUFFA F FIACCHINI M BACCARANI M TESTONI N ZAMAGNI D ZACCARIA A DAMIANI D MICHIELI M ALIMENA G MONTEFUSCO E MANDELLI F MORRA E BERNASCONI C GUGLIELMI P CACCIOLA E BATTISTA R DINI E SPECCHIA G LISO V MAJOLINO I CARONIA F LEONI P DANIELI G NOSARI A DECATALDO F PAOLINO F RESEGOTTI L COMOTTI B BARBUI T SCAPOLI GL CASTOLDI GL PROSSOMARITI L MONTUORI R RICCARDI A ASCARI E LANDOLFI R BIZZI B LOMBARDO M TORLONTANO G LEONI F FERRINI PR SPARAVENTI G DELFINI C PAPINESCHI F SPREMOLLA G BROCCIA G NARDELLI S CICCONE F DERIU L MIRAGLIA E DEBIASE R BODENIZZA CA CAROTENUTO M ROTONDO SG GENTILINI I COSER P CAPUCCI A IZZI T LUCIANO L ROTOLI B IACOPINO P NOBILE F CANTONETTI M PAPA G PINOTTI G SALA G FOA P MAIOLO MT AVANZINI P GOBBI F DORE F PARDINI S AMBROSETTI A PERONA G DINI D LIBERATI AM MARTELLI M GRIGNANI F MONTUORO A DELAURENZI A GALLO E PILERI A GALLAMINI A BUFFA F ABBADESSA A BRUZZESE L DEROSA C CIMINO R MANGONI L RIZZOLI V PIZZUTI M RICCIUTI F GALIENI P DISPENSA E ZAGONEL V PINTO A MUSOLINO C SQUADRITO G PERRICONE R CAJOZZO A MORANDI S BIANCHINI E MILIANI A MONACO M DIFRANCESCO A QUAGLINO D ROSTI G MARANGOLO M PASINI FL DIPERRI T AGLIETTA M GAVOSTO F
Citation: S. Tura et al., EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN1984 AND 1986, British Journal of Haematology, 85(2), 1993, pp. 292-299
Risultati: 1-19 |